Atopy: a risk factor of refractory mycoplasma pneumoniae pneumonia?
Authors:
- 19 December 2015
- journal article
- research article
- Published by Wiley in The Clinical Respiratory Journal
- Vol. 11 (6) , 931-934
Abstract
Objective: To investigate the relationship of pathogen DNA copies with clinic and laboratory features among children with Mycoplasma pneumoniae (MP) pneumonia.Methods: A total of 95 enrolled children with MP pneumonia were assigned into the high‐MP‐load group (>106/mL) and the low‐MP‐load group (≤106/mL) according to MP‐DNA copies in bronchoalveolar lavage fluid (BALF). Clinical characteristics and any allergy history were collected. Aeroallergens and food allergens were detected with a skin test. Serum IgE and eosinophil cationic protein (ECP) were assessed using enzyme immunoassay. BALF levels of IL‐4, IFN‐γ, IL‐8 and TNF‐α were assessed by ELISA.Results: Compared with the low‐MP‐load group, 72.7% in the high‐MP‐load group developed refractory MP pneumonia who failed to respond to at least 1‐week treatment with macrolides (72.7% vs 41.9%, P = 0.005). More children in the high‐load group than those in the low‐load group presented with extrapulmonary manifestations, lung consolidation, pleural effusion and atopic conditions including any allergy history, positive findings of aeroallergen test and increased serum IgE and ECP (P < 0.05). A significant higher BALF IL‐4 level was seen in the high‐load group versus the low‐load group (23.00 ± 11.24 vs 14.68 ± 7.12; pg/mL; P < 0.01). There were no significant differences in BALF levels of IFN‐γ, IL‐8 and TNF‐α between the two groups (P > 0.05).Conclusion: Atopy may be a risk factor for the presence and severity of refractory MP pneumonia due to the high pathogen load in airway.Keywords
Funding Information
- National Natural Science Foundation of China (81172782)
- Shanghai Science and Technology Commission Foundation (14411964800)
This publication has 13 references indexed in Scilit:
- Novel aspects on the pathogenesis of Mycoplasma pneumoniae pneumonia and therapeutic implicationsFrontiers in Microbiology, 2014
- Increased risk of refractoryMycoplasma pneumoniaepneumonia in children with atopic sensitization and asthmaKorean Journal of Pediatrics, 2014
- Macrolide-Resistant Mycoplasma pneumoniae Pneumonia in Adolescents and Adults: Clinical Findings, Drug Susceptibility, and Therapeutic EfficacyAntimicrobial Agents and Chemotherapy, 2013
- Surveillance of Macrolide-Resistant Mycoplasma pneumoniae in Beijing, China, from 2008 to 2012Antimicrobial Agents and Chemotherapy, 2013
- Epidemiology and clinical manifestations of children with macrolide‐resistant Mycoplasma pneumoniae pneumonia in TaiwanPediatric Pulmonology, 2012
- Children With Asthma Hospitalized With Seasonal or Pandemic Influenza, 2003–2009Pediatrics, 2011
- Clinical severity of Mycoplasma pneumoniae(MP) infection is associated with bacterial load in oropharyngeal secretions but not with MP genotypeBMC Infectious Diseases, 2010
- Risk factors and outcomes among children admitted to hospital with pandemic H1N1 influenzaCanadian Medical Association Journal, 2009
- Methylprednisolone pulse therapy for refractory Mycoplasma pneumoniae pneumonia in childrenJournal of Infection, 2008
- Th2 cytokines and asthma — Interleukin-4: its role in the pathogenesis of asthma, and targeting it for asthma treatment with interleukin-4 receptor antagonistsRespiratory Research, 2001